Testing Operations Laboratory Services
The Testing Laboratory at OBI is among the best in the nation and continues to remain on the forefront of cutting-edge technology in developing new and improved ways to maintain the safest blood supply possible.
When Acquired Immune Deficiency Syndrome (AIDS) became a safety concern of the blood supply in 1985, OBI helped develop the original HIV Antigen test that was eventually used throughout the United States.
OBI was also the first to implement Individual Donor Nucleic Acid Testing (NAT) for HIV and West Nile Virus, the first to perform free cholesterol testing as a donor benefit, the first to offer prostate-specific antigen (PSA) blood testing to men for prostate cancer screening, and the first to provide hepatitis B antibody testing.
OBI has also been instrumental in providing data and assistance with several studies such as Chagas, West Nile Virus, and Hepatitis B Virus.
OBI is a Food and Drug Administration (FDA) licensed facility. OBI also holds current certifications for the Clinical Laboratory Improvement Act (CLIA) as well as accreditation with the American Association of Blood Banks, the Florida Agency for Health Care Administration, and the New York State Department of Health.
The Oklahoma Blood Institute’s Testing Laboratory maintains internal Quality Control programs and proficiency testing. Blood specimens are processed utilizing advanced technology with FDA licensed test kits and reagents.